Our April Lancet #HIV 'In conversation with' podcast brings some good news from Botswana. Drew Voetsch and Robert Selato share with us the latest data on the progress of Botswana towards achieving the UNAIDS 95 targets.
Listen here:
buzzsprout.com/1062154/148554…

High acceptability and tolerability of long-acting cabotegravir or rilpivirine injections in the (IMPAACT 2017/MOCHA) trial suggests that these might be favoured treatment options for some adolescents living with #HIV .

thelancet.com/journals/lanhi…

Is the term #AIDS still meaningful in the #HIV discourse or it just perpetuates stigma? Language matters and the latest Viewpoint by Isaac Núñez published in our March issue explores the history of this term and debates about its future.
Sergio Iván Valdés, MD, PhD
buff.ly/43lDDdR

On International Women's Day, we recognize the pivotal role women play in the fight against #HIV . Despite facing disproportionate burdens, women continue to drive important gains in HIV prevention and treatment #SDG5 #IWD2024
Read our March Editorial:
thelancet.com/journals/lanhi…

Position paper sheds light on the ongoing disparities faced by women and gender diverse individuals in HIV research and care. Learn about the NIH's new framework addressing these challenges and advancing equity in HIV.
NIH Women's Health #IWD2024 #InvestInWomen
thelancet.com/journals/lanhi…

Discover research relating to the inclusion and empowerment of women and girls across a broad range of disciplines and contexts including health, climate change, sustainable development, leadership and more. sdgresources.relx.com/special-issues… #SDG5 #IWD2024 #InspireInclusion

Our first bulletin of news from #CROI2024 is out now: STIs in San Francisco have fallen since doxyPEP roll-out, Tuesday 5 March 2024
aidsmap.com/bulletin/confe…
Translated editions will be available later today.